Sensei biotherapeutics appoints kristian humer to its board of directors

Boston, aug. 02, 2021 (globe newswire) -- sensei biotherapeutics, inc. (nasdaq: snse), an immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today announced the appointment of kristian humer, former managing director of banking, capital markets & advisory for the global healthcare team at citigroup, inc. as an independent director to the company's board of directors, effective july 30, 2021.
SNSE Ratings Summary
SNSE Quant Ranking